NFL Biosciences SA (EPA: ALNFL)
France
· Delayed Price · Currency is EUR 1.766
-0.084 (-4.54%)
Dec 20, 2024, 5:35 PM CET
NFL Biosciences Market Cap
NFL Biosciences has a market cap or net worth of €17.14 million as of December 20, 2024. Its market cap has increased by 42.86% in one year.
Market Cap
17.14M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.77
Market Cap Chart
Since July 5, 2021, NFL Biosciences's market cap has decreased from 19.47M to 17.14M, a decrease of -11.98%. That is a compound annual growth rate of -3.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 17.14M | 46.82% |
| Dec 29, 2023 | 11.67M | 13.49% |
| Dec 30, 2022 | 10.29M | -18.13% |
| Dec 31, 2021 | 12.56M | -35.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sanofi | 114.70B |
| EssilorLuxottica Société anonyme | 105.93B |
| Sartorius Stedim Biotech S.A. | 18.00B |
| bioMérieux S.A. | 11.95B |
| Eurofins Scientific SE | 9.03B |
| Ipsen S.A. | 8.87B |
| Virbac SA | 2.61B |
| Ramsay Générale de Santé SA | 1.26B |